Merck & Co has out-licensed its gene therapy portfolio to a new Finland-based company, FKD Therapies Oy, that was founded in early 2011 to source and develop gene-based medicines. Merck has taken an undisclosed equity stake in the company. ---Subscribe to MedNous to access this article--- Company News